via News-Medical.Net
Drug therapy may effectively treat a potentially life-threatening condition associated with cirrhosis and other chronic liver diseases, according to a new study by Mayo Clinic researchers. The study was posted in March on Gastroenterology, the online journal of the American Gastroenterological Association. Print publication is scheduled for July.
While therapies have been available to treat some forms of liver disease, including hepatitis C and autoimmune hepatitis, options have been more limited for treating portal hypertension, a condition where there is an increase in pressure within the portal vein that carries blood from abdominal organs to the liver. Portal hypertension is associated with cirrhosis and other chronic liver diseases.
According to the study, the drug sivelestat may effectively lower portal hypertension, improving symptoms and outcomes for those patients. The study results were obtained from mouse models but have since been confirmed in liver samples from humans, according to Vijay Shah, M.D., a Mayo Clinic gastroenterologist and senior author.
“This was an exciting confirmation of our findings and their applicability to human disease,” Dr. Shah says. “Sivelestat has been safely used in humans with acute lung injury and bronchopulmonary dysplasia. This suggests that sivelestat and similar drugs constitute a potential means to decrease portal hypertension in patients with chronic liver disease.”
The Mayo study showed that deposits of fibrin — microvascular blood clots — contributed to portal hypertension, and inflammatory cells known as neutrophils contributed to the formation of fibrin. By inhibiting neutrophil function with sivelestat, they were able to decrease portal hypertension.
“Neutrophils had not previously been identified as significant drivers of portal hypertension,” says Moira Hilscher, M.D., the paper’s first author. Results were verified in two different models of chronic liver disease.
“The study paves the way for developing new drugs and repurposing of existing compounds to target inflammation in the liver driven by disease-related mechanical forces,” says Dr. Hilscher. “Given the increasing prevalence of advanced liver disease due to alcohol and obesity, this is clearly an unmet need.”
Learn more: Mayo Clinic researchers identify potential new therapy for liver diseases
The Latest on: Liver diseases
Hard-drinking young adults suffer surge in deadly liver disease - Chicago Tribune
September 6, 2019 - Hard-drinking young adults suffer surge in deadly liver disease Chicago TribunePeople ages 25 to 34 represent the greatest increase in deaths driven by alcohol-related liver cirrhosis — a nearly 11% increase per year from 2009 to 2017.
When liver disease affects the brain - Medical Xpress
August 19, 2019 - When liver disease affects the brain Medical XpressScientists have demonstrated how chronic liver diseases cause molecular changes in the brain. They carried out their research using the 9.4 Tesla ...
Liver disease: New intelligent testing could save thousands of lives - Medical Xpress
August 22, 2019 - Liver disease: New intelligent testing could save thousands of lives Medical XpressSince the 1970s, liver disease in the UK has increased by more than 400%, particularly in people under 65—in marked contrast to all other major causes of ...
Pipeline update: 7 reports on autoimmune liver disease therapies - Healio
August 26, 2019 - Pipeline update: 7 reports on autoimmune liver disease therapies HealioAutoimmune liver diseases include primary biliary cholangitis, primary sclerosing cholangitis, and pediatric diseases such as biliary atresia and progressive ...
How chronic liver diseases cause molecular changes in the brain? - Tech Explorist
August 19, 2019 - How chronic liver diseases cause molecular changes in the brain? Tech ExploristScientists found that molecular changes affect the brain as early as the second week of liver disease. And yet, the rats have minimal symptoms of the disease.
Flavors of San Diego is a culinary fundraiser for the American Liver Foundation - - KUSI
September 6, 2019 - Flavors of San Diego is a culinary fundraiser for the American Liver Foundation - KUSISAN DIEGO (KUSI) – Flavors of San Diego is a culinary fundraiser that provides guests with the opportunity of having a top local chef prepare a multi-course ...Liver disease: how new intelligent testing could save thousands of lives - The Conversation UK
August 21, 2019 - Liver disease: how new intelligent testing could save thousands of lives The Conversation UKSince the 1970s, liver disease in the UK has increased by more than 400%, particularly in people under 65 – in marked contrast to all other major causes of ...
Avatrombopag for the treatment of immune thrombocytopenia and thromboc | JBM - Dove Medical Press
September 4, 2019 - Avatrombopag for the treatment of immune thrombocytopenia and thromboc | JBM Dove Medical PressAbraham Z Cheloff, Hanny Al-Samkari Division of Hematology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA Correspondence: ...
Texas leads the nation in liver cancer mortality - TribTalk
August 29, 2019 - Texas leads the nation in liver cancer mortality TribTalkUT Southwestern physicians and scientists perform extensive research in the field of liver disease and are among the leaders in sharing their findings.Rare Disease Leads To Liver Transplant For Parker Toddler, Kennedie Knakmuhs - CBS Denver
September 3, 2019 - Rare Disease Leads To Liver Transplant For Parker Toddler, Kennedie Knakmuhs CBS DenverPARKER, Colo. (CBS4) – A toddler in Parker is one in 100,000. That's how many babies worldwide are born with a life-threatening liver disease called ...
via Google News
The Latest on: Liver diseases
- ‘He’s worth saving’: Mother pleads for exception after son’s past drinking keeps him from a liver transplanton September 6, 2019 at 7:08 pm
Terry's case sheds light on the plight of patients with alcohol-associated liver disease who are still hitting roadblocks to get a spot on the liver transplant list. The sobriety requirement was ...
- FDA approves first treatment for patients with rare type of lung diseaseon September 6, 2019 at 5:10 pm
Interstitial lung disease or ILD is a condition affecting ... includes warnings for patients with moderate or severe hepatic (liver) impairment, those with elevated liver enzymes and drug-induced ...
- Why Amgen's Spending Billions to Buy This 1 Drug; Plus Heart Disease Has a New Enemyon September 6, 2019 at 12:06 pm
You're talking about hypertension, something we've talked about on the show quite a bit; fatty liver disease, which is NASH. It also gives Alnylam some near-term revenues -- when the drug is approved, ...
- Hard-drinking young adults suffer surge in deadly liver diseaseon September 6, 2019 at 6:47 am
A little over a year ago, Eric Dunham had the operation that saved his life: a double transplant to give him a new liver and a new kidney. Chronic, heavy drinking had destroyed his own organs. It also ...
- Ed Henry returns to 'Fox & Friends' after liver donation to sister, shares funny Hannity storyon September 6, 2019 at 6:41 am
who has battled a degenerative liver disease. In an emotional interview in front of a special live audience of first responders, Henry said he was touched by the many letters he received from Fox News ...
- Mechanisms and disease implications of sirtuin-mediated autophagic regulationon September 5, 2019 at 11:34 pm
Here, we describe various biological and pathophysiological processes regulated by sirtuin-mediated autophagy, focusing on cancer, heart, and liver diseases, as well as stem cell biology. This review ...
- Cincinnati La Salle offensive line coach has holiday liver transplanton September 5, 2019 at 7:07 pm
For nearly a year, Tom Doerger has had primary sclerosing cholangitis (PSC), a long-term progressive disease of the liver and gallbladder. It's an auto-immune disease related to ulcerative colitis, ...
- Non-Invasive Liver Assessment: Interview with Echosens’ New CEO Dominique Legroson September 4, 2019 at 9:55 am
Echosens is a medical device company based in Paris, France that’s focused on diagnosing liver disease. Their technology, called FibroScan, uses ultrasonic waves to non-invasively measure the ...
- Rare Disease Leads To Liver Transplant For Parker Toddler, Kennedie Knakmuhson September 2, 2019 at 3:53 pm
PARKER, Colo. (CBS4) – A toddler in Parker is one in 100,000. That’s how many babies worldwide are born with a life-threatening liver disease called progressive familial intrahepatic ...
- Keto diet and others could contribute to nonalcoholic fatty liver diseaseon August 30, 2019 at 6:32 am
If you're looking to shed a few pounds, you might be tempted to try out popular new approaches like the keto diet or fasting. But you might be unwittingly worsening a problem you don't even know ...
via Bing News
